Elevated Levels of Serum IL-17A Secondary to Repeated Intravitreal Injections of Aflibercept in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

Elevated Levels of Serum IL-17A Secondary to Repeated Intravitreal Injections of Aflibercept in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

We evaluated the effect of three monthly intravitreal injections of aflibercept on the serum concentration of interleukin 17A (IL-17A), monocyte chemoattractant protein 1 (MCP-1/CCL2), vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in treatment-naive patients with neova...

Full description

Bibliographic Details
Main Authors: Małgorzata Seredyka-Burduk, Michał Wiciński, Sławomir Liberski, Daria Marczak, Magdalena Pol, Bartosz Malinowski, Bartlomiej J. Kaluzny
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Applied Sciences
Subjects:
aflibercept
interleukin-17
IL-17
monocyte chemoattractant protein 1
MCP-1/CCL2
vascular endothelial growth factor
Online Access:https://www.mdpi.com/2076-3417/10/12/4109

Internet

https://www.mdpi.com/2076-3417/10/12/4109

Similar Items